Revolution Medicines Investor Relations Material
Latest events
Q4 2023
Revolution Medicines
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Revolution Medicines Inc
Access all reports
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The Company's portfolio includes programs that target shared signaling mutations involving RAS and EGFR pathways. Through its technology platform of small molecules that enter cells through multiple mechanisms of action, Revolution Medicines aims to significantly increase drug concentrations at key adverse driver points required for cell growth and survival.
Key slides for Revolution Medicines Inc
Corporate Presentation
Revolution Medicines Inc
Corporate Presentation
Revolution Medicines Inc
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇺🇸 United States